Company Theseus Pharmaceuticals, Inc.
Equities
THRX
US88369M1018
Biotechnology & Medical Research
Business Summary
Number of employees: 38
Managers
Managers | Title | Age | Since |
---|---|---|---|
- | - | ||
59 | - | ||
66 | - | ||
Bradford Dahms
PSD | President | 36 | 30/04/21 |
Leonard Rozamus
CTO | Chief Tech/Sci/R&D Officer | - | - |
Katie Dahlstrom
CTO | Chief Tech/Sci/R&D Officer | - | - |
Investor Relations Contact | - | - | |
Corporate Officer/Principal | - | - | |
Benjamin Enerson
LAW | General Counsel | - | - |
Comptroller/Controller/Auditor | - | 31/05/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bradford Dahms
PSD | President | 36 | 30/04/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,649,172 | 44,649,172 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-4.08% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |